CalcMyPeptide

GLP-1 Dose Escalation Scheduler

GLP-1 receptor agonists require gradual dose escalation to minimize gastrointestinal side effects. Select your medication below and enter your start date to generate a complete week-by-week schedule with injection dates and syringe units.

GLP-1 剂量计划器

GLP-1 RA · Once weekly

您当前周次Month 1

0.25毫克(mg)

周次 1 · Wegovy

1

周(共 20

下次加量: 0.5 毫克(mg) in 4 (周次 5)

增量时间表

0.25 毫克(mg)
0.5 毫克(mg)
1 毫克(mg)
1.7 毫克(mg)
2.4 毫克(mg)
1 20
日期剂量
13/23/20260.25 毫克(mg)
23/30/20260.25 毫克(mg)
34/6/20260.25 毫克(mg)
44/13/20260.25 毫克(mg)
54/20/20260.5 毫克(mg)
64/27/20260.5 毫克(mg)
75/4/20260.5 毫克(mg)
85/11/20260.5 毫克(mg)
95/18/20261 毫克(mg)
105/25/20261 毫克(mg)
116/1/20261 毫克(mg)
126/8/20261 毫克(mg)
136/15/20261.7 毫克(mg)
146/22/20261.7 毫克(mg)
156/29/20261.7 毫克(mg)
167/6/20261.7 毫克(mg)
177/13/20262.4 毫克(mg)
187/20/20262.4 毫克(mg)
197/27/20262.4 毫克(mg)
208/3/20262.4 毫克(mg)

数据源: FDA Label (Wegovy) / STEP 1 Trial · 体重减轻: ~15% · t½: ~7

Supported Protocols

Semaglutide (Wegovy)

GLP-1 Agonist

0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg

Source: FDA Label

Semaglutide (Ozempic)

GLP-1 Agonist

0.25 → 0.5 → 1.0 mg

Source: FDA Label

Tirzepatide (Mounjaro)

Dual GIP/GLP-1

2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg

Source: FDA Label

Retatrutide (Phase II)

Triple Agonist

1 → 2 → 4 → 8 → 12 mg

Source: PMID: 37351564

Explore the Compounds

Dive into detailed profiles covering mechanism of action, clinical trial data, and dosing calculations.

Related Tools